News
EMA grants orphan drug designation to Purespring Therapeutics’ PS-002 to treat patients with primary IgA nephropathy: London Tuesday, April 29, 2025, 13:00 Hrs [IST] Purespring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback